| Active substance |
Mesterolone |
| Also known as |
Virazole, Tribavirin |
| Blood pressure |
No significant effect on blood pressure |
| Chemical name |
1-ОІ-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide |
| Dosage (medical) |
Typically 200 to 1200 mg per day in divided doses, depending on the condition being treated |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces viral replication |
| Formula |
C8H12N4O5 |
| Half-life |
120 to 170 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Monitoring of hemoglobin levels and liver enzymes |
| Main action |
Inhibits viral mRNA synthesis |
| Side effects |
Hemolytic anemia, fatigue, headache, fever, rash, nausea, cough, and insomnia |
| Storage conditions |
Store at room temperature, 15-30В°C (59-86В°F) |
| Strength |
25mg |
| Substance class |
Nucleoside analogue antiviral |
| Trade name |
Rebetol, Copegus |
| Use in sports |
None |
| Water Retention |
No significant effect |
| Manufacturer |
Consern Pharma Pvt. Ltd. |
| Packing |
10 tabs/blister |
